Jack Meehan
Stock Analyst at Barclays
(3.06)
# 1,333
Out of 4,974 analysts
136
Total ratings
69.51%
Success rate
21.33%
Average return
Main Sectors:
Stocks Rated by Jack Meehan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Maintains: Equal-Weight | $250 → $275 | $275.23 | -0.08% | 16 | Jun 25, 2025 | |
| A Agilent Technologies | Maintains: Underweight | $120 → $125 | $128.48 | -2.71% | 20 | Feb 28, 2024 | |
| WAT Waters | Maintains: Equal-Weight | $275 → $288 | $299.69 | -3.90% | 10 | Aug 3, 2023 | |
| AVTR Avantor | Initiates: Overweight | $33 | $13.19 | +150.19% | 3 | Mar 3, 2021 | |
| ILMN Illumina | Initiates: Underweight | $325 | $97.68 | +232.72% | 8 | Mar 3, 2021 | |
| INMD InMode | Maintains: Overweight | $18 → $19 | $14.41 | +31.85% | 3 | Aug 17, 2020 | |
| DGX Quest Diagnostics | Maintains: Equal-Weight | $93 → $99 | $180.11 | -45.03% | 7 | Apr 23, 2020 | |
| ICLR ICON Public Limited Company | Maintains: Overweight | $170 → $180 | $176.11 | +2.21% | 2 | Apr 23, 2020 | |
| MYGN Myriad Genetics | Maintains: Underweight | $14 → $10 | $6.79 | +47.28% | 8 | Mar 26, 2020 | |
| IQV IQVIA Holdings | Maintains: Overweight | $192 → $166 | $184.08 | -9.82% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $43 | $66.36 | -35.20% | 9 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $154 | $162.31 | -5.12% | 7 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $289.43 | +48.57% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $435 → $430 | $285.92 | +50.39% | 6 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $27.79 | - | 10 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $52 → $48 | $29.79 | +61.13% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $720 → $680 | $1,287.79 | -47.20% | 4 | Mar 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $30 | $95.49 | -68.58% | 3 | Oct 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $295 → $300 | $489.49 | -38.71% | 5 | Mar 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $40 | $1.58 | +2,438.55% | 1 | Dec 11, 2017 |
Labcorp Holdings
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $250 → $275
Current: $275.23
Upside: -0.08%
Agilent Technologies
Feb 28, 2024
Maintains: Underweight
Price Target: $120 → $125
Current: $128.48
Upside: -2.71%
Waters
Aug 3, 2023
Maintains: Equal-Weight
Price Target: $275 → $288
Current: $299.69
Upside: -3.90%
Avantor
Mar 3, 2021
Initiates: Overweight
Price Target: $33
Current: $13.19
Upside: +150.19%
Illumina
Mar 3, 2021
Initiates: Underweight
Price Target: $325
Current: $97.68
Upside: +232.72%
InMode
Aug 17, 2020
Maintains: Overweight
Price Target: $18 → $19
Current: $14.41
Upside: +31.85%
Quest Diagnostics
Apr 23, 2020
Maintains: Equal-Weight
Price Target: $93 → $99
Current: $180.11
Upside: -45.03%
ICON Public Limited Company
Apr 23, 2020
Maintains: Overweight
Price Target: $170 → $180
Current: $176.11
Upside: +2.21%
Myriad Genetics
Mar 26, 2020
Maintains: Underweight
Price Target: $14 → $10
Current: $6.79
Upside: +47.28%
IQVIA Holdings
Mar 26, 2020
Maintains: Overweight
Price Target: $192 → $166
Current: $184.08
Upside: -9.82%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $51 → $43
Current: $66.36
Upside: -35.20%
Mar 26, 2020
Maintains: Equal-Weight
Price Target: $170 → $154
Current: $162.31
Upside: -5.12%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $289.43
Upside: +48.57%
Mar 26, 2020
Maintains: Overweight
Price Target: $435 → $430
Current: $285.92
Upside: +50.39%
Mar 26, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $27.79
Upside: -
Mar 26, 2020
Upgrades: Overweight
Price Target: $52 → $48
Current: $29.79
Upside: +61.13%
Mar 26, 2020
Upgrades: Equal-Weight
Price Target: $720 → $680
Current: $1,287.79
Upside: -47.20%
Oct 2, 2019
Maintains: Underweight
Price Target: $28 → $30
Current: $95.49
Upside: -68.58%
Mar 18, 2019
Maintains: Overweight
Price Target: $295 → $300
Current: $489.49
Upside: -38.71%
Dec 11, 2017
Initiates: Equal-Weight
Price Target: $40
Current: $1.58
Upside: +2,438.55%